Brainsway Ltd.
BWAY- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001505065
No open-market purchases or sales by Brainsway Ltd. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $176.9M in total; ARK Invest is the only superinvestor holding it.
Other share classesBRSYF
13F holders, Q3 2022
Institutional positions in Brainsway Ltd. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −2 vs. Q2 2022
- Shares held
- 7.05M
- −34.3K (−0.5%) vs. Q2 2022
- Total value
- $25.8M
- −$8.79M (−25.4%) vs. Q2 2022
- New holders
- 0
- 5 more added
- Sold out
- 2
- 5 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BWAY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 55 | $176.9M |
| Q1 2026 | 56 | $155.6M |
| Q4 2025 | 43 | $112.6M |
| Q3 2025 | 44 | $81.6M |
| Q2 2025 | 42 | $75.7M |
| Q1 2025 | 42 | $56.7M |
| Q4 2024 | 39 | $56.1M |
| Q3 2024 | 32 | $30.2M |
| Q2 2024 | 27 | $21.7M |
| Q1 2024 | 29 | $19.8M |
| Q4 2023 | 27 | $28.7M |
| Q3 2023 | 15 | $16.3M |
| Q2 2023 | 16 | $9.33M |
| Q1 2023 | 15 | $6.68M |
| Q4 2022 | 16 | $13.0M |
| Q3 2022 | 16 | $25.8M |
| Q2 2022 | 18 | $34.5M |
| Q1 2022 | 18 | $62.7M |
| Q4 2021 | 23 | $55.0M |
| Q3 2021 | 19 | $57.0M |
| Q2 2021 | 23 | $77.6M |
| Q1 2021 | 25 | $66.3M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Brainsway Ltd.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| RTW Investments, LP | 1,602,381 | $5.79M | 0.13% | 00.0% | Unchanged |
| Wasatch Advisors Inc | 1,264,918 | $4.63M | 0.03% | −20,713−1.6% | Reduced |
| Morgan Stanley | 1,035,211 | $3.74M | 0.00% | 00.0% | Unchanged |
| Cowen and Company, LLC | 916,909 | $3.36M | 0.32% | 00.0% | Unchanged |
| Masters Capital Management LLC | 900,000 | $3.25M | 0.96% | 00.0% | Unchanged |
| Phoenix Holdings Ltd. | 836,895 | $3.21M | 0.07% | −38,486−4.4% | Reduced |
| DAFNA Capital Management LLC | 220,000 | $794.0K | 0.21% | +20,000+10.0% | Added |
| Taylor Frigon Capital Management LLC | 205,698 | $743.0K | 0.39% | +1,622+0.8% | Added |
| Raymond James & Associates | 26,231 | $95.0K | 0.00% | +13,631+108.2% | Added |
| Psagot Value Holdings Ltd. / (Israel) | 16,198 | $58.0K | 0.02% | +7,898+95.2% | Added |
| Millennium Management LLC | 15,323 | $56.0K | 0.00% | +715+4.9% | Added |
| Advisor Group Holdings, Inc. | 4,149 | $15.0K | 0.00% | −212−4.9% | Reduced |
| Financial Perspectives, Inc | 2,955 | $10.7K | 0.01% | 00.0% | Unchanged |
| Essex Investment Management Co LLC | 1,700 | $6.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 200 | $1.00K | 0.00% | −529−72.6% | Reduced |
| UBS Group AG | 333 | $1.00K | 0.00% | −33−9.0% | Reduced |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −17,184−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |